14 results
F-1/A
EX-10.2
CNTB
Connect Biopharma Holdings Ltd
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
, controversy or difference between the parties hereto arising out of, in connection with or relating to, this Agreement (a “Dispute”) shall be resolved
F-1
EX-10.5
CNTB
Connect Biopharma Holdings Ltd
26 Feb 21
Registration statement (foreign)
4:56pm
) In the event of any dispute, controversy or claim arising from or related to a material breach of this Agreement or termination pursuant to Section … or the controversy is otherwise resolved. Either party also may, without waiving any remedy under this Agreement, seek from any court having jurisdiction any
DRS/A
EX-10.5
CNTB
Connect Biopharma Holdings Ltd
26 Jan 21
Draft registration statement (amended)
12:00am
) In the event of any dispute, controversy or claim arising from or related to a material breach of this Agreement or termination pursuant to Section … or the controversy is otherwise resolved. Either party also may, without waiving any remedy under this Agreement, seek from any court having jurisdiction any
F-1
EX-10.11
CNTB
Connect Biopharma Holdings Ltd
26 Feb 21
Registration statement (foreign)
4:56pm
. Arbitration. Any dispute, claim or controversy based on, arising out of or relating to Executive’s employment or this Agreement shall be settled by final
DRS
EX-4.4
CNTB
Connect Biopharma Holdings Ltd
17 Dec 20
Draft registration statement
12:00am
or otherwise delaying any registration pursuant to this Agreement as the result of any controversy that might arise with respect to the interpretation … , without regard to principles of conflict of Laws thereunder.
16.2 Dispute Resolution.
(a) Any dispute, controversy or claim (each, a “Dispute”) arising
F-1
EX-4.4
ymyvnik
26 Feb 21
Registration statement (foreign)
4:56pm
6-K
EX-99.1
mijbo gnm8qp
21 Nov 23
Exclusive License and Collaboration Agreement
6:13am
F-1/A
wxk8gsezkb5ahp0g1e9
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
F-1
q4e8jl5w
26 Feb 21
Registration statement (foreign)
4:56pm
424B4
zlb36pz1uv7j
19 Mar 21
Prospectus supplement with pricing info
4:49pm
20-F
9vwvpe3ws4c dhbp8
31 Mar 22
Annual report (foreign)
4:33pm
DRS/A
69vsmpmrod2l4f27bie
26 Jan 21
Draft registration statement (amended)
12:00am
DRS
ncn2uj
17 Dec 20
Draft registration statement
12:00am
F-1/A
ew4u685
18 Mar 21
Registration statement (foreign) (amended)
6:15am
- Prev
- 1
- Next